LexDanaLexDanabeta
Inventor

Stephane Pintat

Inventor
Abingdon, GB

Overview

6→
Patents
2011–2019
Patent span
Human necessities
Primary field (CPC A)

Patents· 6 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations35%
C07DHeterocyclic compounds35%
A61KPreparations for medical, dental or toiletry purposes29%
PatentTitleYear
10,370,332Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-YL]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof20199,896,417'Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt,hydrate or solvate thereof'20189,604,940'2-aminopyrazine derivatives as CSF-1R kinase inhibitors'20179,388,136'Tert-butyl N-[2-{4-[6-amino-5-(2,4-difluorobenzoyl)-2-oxopyridin-1(2H)-yl]-3,5-difluorophenyl}ethyl]-L-alaninate or a salt, hydrate or solvate thereof'20168,778,953'Inhibitors of P38 map kinase'20148,044,211'P38 MAP kinase inhibitors'2011

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2011–2018Patents assigned to CHROMA THERAPEUTICS LTD (5)· patent assignee history
2011–2019Based in Abingdon, GB· patent location history
2014Patents assigned to DAVIES STEPHEN JOHN (1)· patent assignee history
2014Patents assigned to MOFFAT DAVID FESTUS CHARLES (1)· patent assignee history
2014Patents assigned to PINTAT STEPHANE (1)· patent assignee history
2018–2019Patents assigned to MACROPHAGE PHARMA LTD (2)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
CHROMA THERAPEUTICS LTD52011–2018
MACROPHAGE PHARMA LTD22018–2019
DAVIES STEPHEN JOHN12014
MOFFAT DAVID FESTUS CHARLES12014
PINTAT STEPHANEself12014
Locations
LocationPatentsSpan
Abingdon, GB62011–2019